|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Structure solution with three-dimensional sets of precessed electron diffraction intensities显示文摘 | Gemmi M Nicolopoulos S | 2007 | Ultramicroscopy2007，107，： | 1 |
| 2 | The mechanism of action of rituximab in the elimination of tumor ceils显示文摘 | JOHNSON P GEMMIE M | 2003 | Semin Oncol2003，30，2： | 1 |
| 3 | Refractive Errors and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis显示文摘 | Chen-Wei Pan M. Kamran Ikram Carol Y. Cheung Hyung-Won Choi Chiu-Ming Gemmy Cheung Jost B. Jonas Seang-Mei Saw Tien-Yin Wong | 2013 | Ophthalmology2013，，： | 1 |
| 4 | 显示文摘 | PORTILLO J RAUCH E NICOLOPOULOS S GEMMI M BULTREYS D | 2010 | Mater Sci Forum2010，644，1： | 1 |
| 5 | Relationship of Smoking and Cardiovascular Risk Factors with Polypoidal Choroidal Vasculopathy and Age-related Macular Degeneration in Chinese Persons显示文摘 | Peter Cackett Ian Yeo Chui Ming Gemmy Cheung Eranga N. Vithana Doric Wong Wan Ting Tay E. Shyong Tai Tin Aung Tien Y. Wong | 2011 | Ophthalmology2011，，5： | 1 |
| 6 | 显示文摘 | Gualtieri A F Gemmi M Dapiaggi M | 2003 | American Mineralogist2003，88，： | 1 |
| 7 | Content based and collaborative techniques for tag recommendation:an empirical evaluation显示文摘 | LOPS P GEMMIS M D SEMERARO G | 2013 | Journal of Intelligent Information Systems2013，40，1： | 1 |
| 8 | B-blockade therapy in chronic heart failure:Diastolic function and mitral regurgitation improvement by carvedilol显示文摘 | Capomolla S Febe O Gemmi M | 2000 | Am Heart J2000，13，： | 1 |
| 9 | Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy显示文摘 | Gemmy Cheung CM Yen I Li X | 2013 | Am J Ophthalmol2013，155，： | 1 |
| 10 | Increased neutrophil (Neu) adhesion in bronchial biopsies from patients with severe COPD显示文摘 | Sabatini FD Stefano A Gemmi I | 2008 | Cytometry Part A: the journal of the International Society for Analytical Cytology2008，73，1： | 1 |
| 11 | A real-time PCR approach to evaluate adipogenic potential of anmiotic fluid-derived human megenehymal stem cells显示文摘 | Lapucci c Bertelli M | 2006 | Stem Cells Dev2006，15，5： | 1 |
| 12 | Expression of the EMILIN-1 gene during mouse development显示文摘 | Braghetta P Ferrari A de Gemmis P | 2002 | Matrix Biol2002，21，7： | 1 |
| 13 | Content-based and collaborative techniques for tag recommendation:an empirical evaluation显示文摘 | Lops P Gemmis M D Semeraro G | 2013 | Journal of Intelligent Information Systems2013，40，1： | 1 |
| 14 | In situ simultaneous synchrotron powder diffraction and mass spectrometry study of methane anaerobic combustion on iron-oxide-based oxygen carrier显示文摘 | GEMMI M MERLINI M CORNARO U GHISLETrI D ARTIOLI G | 2005 | J Appl Cryst2005，38，： | 1 |
| 15 | User profiles for personalizing digital libraries//Handbook of Research on Digital Libraries显示文摘 | Semeraro G Basile P de Gemmis M | | 0，，： | 1 |
| 16 | Structure of Ti2P solved by three-dimensional electron diffraction data collected with the precession technique and high-resolution electron microscopy显示文摘 | Gemmi M Zou X D Hovm(o)ller S Migliori A Vennstrom M Andersson Y | 2003 | Acts Crystallographica Section A2003，59，： | 1 |
| 17 | Submacular hemorrhage:treatment update and remaining challenges显示文摘Submacular haemorrhage(SMH)is a sight threatening complication that can occur in exudative age related macular degeneration(AMD),but has been described to occur more frequently in eyes with polypoidal choroidal vasculopathy(PCV).Left untreated,SMH carries a grave visual prognosis.Thus,expedient diagnosis and effective management of this complication is of paramount importance.The treatment strategies for SMH include(I)displacement of blood from the fovea,usually by injection of an expansile gas;(II)pharmacologic clot lysis such as with recombinant tissue plasminogen activator(rtPA);and(III)treatment of the underlying choroidal neovascularization(CNV)or PCV,such as with anti-vascular endothelial growth factor(anti-VEGF)agents.These three strategies have been employed in isolation or in combination,some concurrently and others in stages.rtPA has demonstrable effect on the liquefaction of submacular clots but there are remaining uncertainties with regards to the dose,safety and the timing of initial and repeat treatments.Potential side effects of rtPA include retinal pigment epithelial toxicity,increased risk of breakthrough vitreous haemorrhage and systemic toxicity.In cases presenting early,pneumatic displacement alone with anti-VEGF may be sufficient.Anti-VEGF monotherapy is a viable treatment option particularly in patients with thinner SMH and those who are unable to posture post pneumatic displacement. | Chee Wai Wong Jan Carlo Yu Alegre Yew San Ian Yeo Chui Ming Gemmy Cheung | 2017 | Annals of Eye Science2017，，1： | 0 |
| 18 | Hidden messages in optical coherence tomography:looking beyond fluid显示文摘The outlook for patients with neovascular age-related macular degeneration(AMD)has significantly improved since the advent of anti-vascular endothelial growth factor(anti-VEGF)therapy.Numerous clinical trials have demonstrated favorable visual and anatomical response up to 2 years.However,longer-term results have been variable.Some of this difference has been suggested to be due to difference in treatment exposure after patients exit from randomized control trial(RCT)to real world setting.For example,in the SEVEN-UP study,patients received only an average of 1.6 injections/year during the 5 years after exit from the trial. | Chui Ming Gemmy Cheung Huan Chen | 2018 | Annals of Eye Science2018，，1： | 0 |
| 19 | Choroidal neovascularization secondary to pathological myopia显示文摘Myopic choroidal neovascularization(m CNV), one of the complications of pathological myopia, is also one of the leading causes of visual impairment worldwide. The socioeconomic impact of mC NV in Asian countries is particularly significant due to the rising incidence of pathological myopia. There have been major advances in the treatment of mC NV in the past few years. Previous treatment modalities, such as thermal laser photocoagulation and photodynamic therapy, aimed to prevent vision loss;however, newer modalities such as intravitreal anti-vascular endothelial growth factor(VEGF) agents have been shown to successfully restore vision in many patients. Challenges remain as long term safety and efficacy of anti-VEGF agents are unknown. This article aims to provide a review of the literature of the epidemiology, progression, clinical course and treatment modalities as well as areas of future developments related to myopic CNV. | Kelvin Teo Chui Ming Gemmy Cheung | 2014 | World Journal of Ophthalmology2014，4，3： | 0 |
| 20 | When to change course:timing of treatment change in the management of diabetic macular edema显示文摘Diabetes mellitus currently affects at least 1 in 40 persons worldwide,and is expected to affect 1 in 20 people by2030(1).Among those affected,approximately one-quarter have diabetic retinopathy(2)and a similar number will go on to develop vision-threatening diabetic | Beau J.Fenner Chui Ming Gemmy Cheung | 2017 | Eye Science2017，32，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员